Senior Clinical Director, Research Oncology, Flatiron Health

Nurse Practitioner, Memorial Sloan Kettering Cancer Center

New York, NY

Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder

Program, Department of Hematologic Oncology and Blood Disorders

Levine Cancer Institute

Charlotte, NC

Professor, Cancer Medicine

Wake Forest University School of Medicine

Winston-Salem, NC

In this episode, Dr. Peter Voorhees from the Levine Cancer Institute and Amy Pierre, MSN, RN, ANP BC from Flatiron Health and Memorial Sloan Kettering, break down the evolving landscape of myeloma, from early signs and diagnostic criteria to frontline therapy, transplant decisions, and T- cell redirecting therapies. They explore real world challenges in survivorship, treatment toxicity, and disparities in access to advanced therapies, offering practical insights to help care teams support patients more effectively. Tune in for an informative and forward looking discussion shaping the future of myeloma management.